DNMT3A and pulmonary arterial hypertension: Thus, several studies have demonstrated the association between upregulated DNMT expression and PAH; however, it is unclear whether and how mutations in DNMT genes, including CHIP-driving DNMT3A mutations, cause PAH, and this remains an active area of investigation in our laboratory.